Definitive Healthcare Corp.DHEarnings & Financial Report
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
DH Q3 2025 Key Financial Metrics
Revenue
$60.0M
Gross Profit
$46.0M
Operating Profit
$-8.7M
Net Profit
$-14.8M
Gross Margin
76.6%
Operating Margin
-14.5%
Net Margin
-24.7%
YoY Growth
-4.2%
EPS
$-0.14
Financial Flow
Definitive Healthcare Corp. Q3 2025 Financial Summary
Definitive Healthcare Corp. reported revenue of $60.0M for Q3 2025, with a net profit of $-14.8M (-24.7% margin). Cost of goods sold was $14.1M, operating expenses totaled $54.7M.
Key Financial Metrics
| Total Revenue | $60.0M |
|---|---|
| Net Profit | $-14.8M |
| Gross Margin | 76.6% |
| Operating Margin | -14.5% |
| Report Period | Q3 2025 |
Definitive Healthcare Corp. Annual Revenue by Year
Definitive Healthcare Corp. annual revenue history includes year-by-year totals (for example, 2024 revenue was $252.2M).
| Year | Annual Revenue |
|---|---|
| 2024 | $252.2M |
| 2023 | $251.4M |
| 2022 | $222.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.9M | $63.5M | $63.7M | $62.7M | $62.3M | $59.2M | $60.8M | $60.0M |
| YoY Growth | 8.8% | 7.2% | 4.6% | -4.0% | -5.5% | -6.8% | -4.7% | -4.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.83B | $1.81B | $1.42B | $1.18B | $1.09B | $808.7M | $770.1M | $755.5M |
| Liabilities | $626.7M | $615.1M | $536.1M | $486.1M | $482.2M | $372.8M | $358.9M | $365.9M |
| Equity | $1.20B | $1.20B | $886.3M | $695.6M | $607.2M | $435.9M | $411.2M | $389.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.7M | $16.6M | $14.0M | $19.4M | $8.1M | $26.1M | $9.3M | $15.7M |